Welcome to the e-CCO Library!

search
Search by: 
Year: Category: Sub Type:
DOP071: Tight control with adalimumab-based treatment is associated with improved quality of life outcomes in patients with moderate to severely active Crohn's Disease: Data from CALM
Year: 2018
Source: ECCO'18 Vienna
Authors: Panaccione Remo
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP071: Tofacitinib plasma concentration monitoring is not needed for optimisation of induction therapy in moderate to severe ulcerative colitis: Results of pooled exposure-response analyses of Phase 3 induction studies
Year: 2016
Source: ECCO'16 DOP
Authors: Su C.
Ulcerative Colitis, therapeutic drug monitoring, tofacitinib
Files: 1
DOP072: Achieving biochemical remission with adalimumab therapy using therapeutic drug monitoring: Results of a large prospective Crohn’s Disease cohort
Year: 2018
Source: ECCO'18 Vienna
Authors: Plevris Nikolas
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP072: Assessment of the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) using central video review of colonoscopies in paediatric patients with Ulcerative Colitis: Data from the Canadian Children IBD Network
Year: 2017
Source: ECCO'17 Barcelona
Authors: Carman N.
Colonoscopy,Treat to target
Files: 1
DOP072: Association of ustekinumab trough concentrations with clinical, biochemical and endoscopic outcomes
Year: 2016
Source: ECCO'16 DOP
Authors: Kopylov U.
therapeutic drug monitoring, ustekinumab
Files: 1
DOP073: Results of the sixth ECCO Scientific Workshop: The pathogenesis of inflammatory extraintestinal manifestations of Inflammatory Bowel Disease - implications for research, diagnosis and therapy
Year: 2018
Source: ECCO'18 Vienna
Authors: Hedin Charlotte R H
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP073: Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided Ulcerative Colitis patients with moderate-to-severe disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Atreya R.
Ulcerative colitis, Firoblast, Lymphocyte
Files: 1
DOP074: IL-33 promotes gut mucosal wound healing by inducing miRNA-320 to stimulate epithelial restitution and repair
Year: 2018
Source: ECCO'18 Vienna
Authors: Lopetuso Loris Riccardo
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP074: Incidence prediction of fistula formation in England
Year: 2016
Source: ECCO'16 DOP
Authors: Sahnan K.
environmental factors, perianal fistulae, non-perianal fistulae, Crohn's Disease
Files: 1
DOP074: Pharmacokinetics and exposure-response of tofacitinib in a Phase 3 maintenance study in Ulcerative Colitis patients
Year: 2017
Source: ECCO'17 Barcelona
Authors: Mukherjee A.
Therapeutic drug monitoring, Pharmacokinetics, Tofacitinib
Files: 1
DOP075: Efficacy of filgotinib, a selective JAK1 inhibitor, is independent of prior anti-TNF exposure: Subgroup analysis of the phase 2 FITZROY study in moderate-to-severe Crohn' Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Vermeire S.
Filgotinib, Crohn's disease
Files: 1
DOP075: Looking beyond symptoms and disease activity to define disease severity in inflammatory bowel disease: results of an IOIBD specialist panel
Year: 2016
Source: ECCO'16 DOP
Authors: Peyrin-Biroulet L.
disease activity indices, Crohn's Disease, Ulcerative Colitis, functional symptoms, disability
Files: 1
DOP076: A Danish cross-sectional study: Autoimmune and chronic inflammatory disorders associated with Ulcerative Colitis.
Year: 2016
Source: ECCO'16 DOP
Authors: Koch Hansen L.
ASSOCIATED AUTOIMMUNE DISEASE
Files: 1
DOP076: A Phase 2B, multicenter, randomised, placebo-controlled dose-ranging trial of peficitinab, an OralL JAK Inhibitor, in patients with moderately to severely active Ulcerative Colitis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Sands B.
Other
Files: 1
DOP077: Deep Immunophenotyping reveals a role for Mucosal Associated Invariant T (MAIT) cells in the response to anti-TNF treatment in Crohn’s Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Walshe Margaret
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP077: Immunochip Analysis Identifies Multiple Susceptibility Loci for Collagenous Colitis
Year: 2016
Source: ECCO'16 DOP
Authors: Roda G.
Microscopic colitis
Files: 1
DOP078: Risk of malignancy in paediatric inflammatory bowel disease: Results from the DEVELOP registry
Year: 2016
Source: ECCO'16 DOP
Authors: Veereman G.
Malignancy, mortality, anti-TNF agents
Files: 1
DOP078: Visceral and subcutaneous adipose tissues of Crohn’s Disease patients contains bacteria
Year: 2018
Source: ECCO'18 Vienna
Authors: Serena Carolina
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP079: Predictors of first neoplastic colonic lesion in patients with inflammatory bowel disease undergoing colonoscopic surveillance
Year: 2016
Source: ECCO'16 DOP
Authors: Kirchgesner J.
Malignancy, mortality, anti-TNF agents, thiopurines (AZA/MP)
Files: 1
DOP079: The role of intestinal transplant in patients with complicated Inflammatory Bowel Disease (IBD): The Cambridge experience
Year: 2017
Source: ECCO'17 Barcelona
Authors: Yeap S.
MDT, Post operative complications,Parenteral nutrition, Intestinal transplantation
Files: 1